Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1996 AL 2010

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease

Zhou F, Zhao Y, Sun Y, Chen W.

J Integr Neurosci. 2024 Oct 30;23(11):197. doi: 10.31083/j.jin2311197.

The role of the FKBP51-Hsp90 complex in Alzheimer's disease: An emerging new drug target

Jeanne X, Török Z, Vigh L, Prodromou C.

Cell Stress Chaperones. 2024 Dec;29(6):792-804. doi: 10.1016/j.cstres.2024.11.006. Epub 2024 Nov 29.

Treatment of Alzheimer Disease

Geldmacher DS.

Continuum (Minneap Minn). 2024 Dec 1;30(6):1823-1844. doi: 10.1212/CON.0000000000001503.

Dysregulation of energy metabolism in Alzheimer's disease

Yuan Y, Zhao G, Zhao Y.

J Neurol. 2024 Dec 2;272(1):2. doi: 10.1007/s00415-024-12800-8.

The Potential Role of Enrichment Environment on Plasticity in Alzheimer's Disease Models: Insights About Therapeutic Approaches

Neves RC, Figueiredo RC, Faria-Melibeu AC.

Curr Alzheimer Res. 2024;21(7):457-469. doi: 10.2174/0115672050348227241128095209.

A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease

Yang H, Byun MS, Ha NY, Yang J, Park SY, Park JE, Yi D, Chang YT, Jung WS, Kim JY, Kim J, Lee DY, Bae H.

Biomed Pharmacother. 2024 Dec;181:117721. doi: 10.1016/j.biopha.2024.117721. Epub 2024 Dec 2.

Polyphenols and Their Biogenic Nano-Formulations Targeting BACE1 as Anti-Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease

Elawad MA, Ayaz M, Mosa OF, Usman A, Hamdoon AAE, Almawash S, Salim LHM, Ahmed A, Elkhalifa MEM.

Mol Nutr Food Res. 2024 Dec;68(24):e2400525. doi: 10.1002/mnfr.202400525. Epub 2024 Dec 4.

Aging-associated sensory decline and Alzheimer's disease

Hong S, Baek SH, Lai MKP, Arumugam TV, Jo DG.

Mol Neurodegener. 2024 Dec 4;19(1):93. doi: 10.1186/s13024-024-00776-y.

Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b Inhibitors

Singh R, Jain S, Paliwal V, Verma K, Paliwal S, Sharma S.

Drug Dev Res. 2024 Dec;85(8):e70026. doi: 10.1002/ddr.70026.

Histone Methylation, Energy Metabolism, and Alzheimer's Disease

Fu J, An L.

Aging Dis. 2024 Nov 15;16(5):2831-2858. doi: 10.14336/AD.2024.0899.

The mechanism and related research progress of GLP-1 receptor agonists in treating Alzheimer's disease

Zhu XC, Wang YW, Zhou HW.

Yi Chuan. 2024 Dec;46(12):1017-1027. doi: 10.16288/j.yczz.24-178.

A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease

Suganya S, Ashok BS, Ajith TA.

Cell Biochem Funct. 2024 Dec;42(8):e70025. doi: 10.1002/cbf.70025.

A meta-analysis of the efficacy of physical exercise interventions on activities of daily living in patients with Alzheimer's disease

Xiao Y, Fan Y, Feng Z.

Front Public Health. 2024 Nov 27;12:1485807. doi: 10.3389/fpubh.2024.1485807. eCollection 2024.

The AICD interactome: implications in neurodevelopment and neurodegeneration

Ng LL, Chow J, Lau KF.

Biochem Soc Trans. 2024 Dec 19;52(6):2539-2556. doi: 10.1042/BST20241510.

Current Update on Promising New Anti-Alzheimer's Drugs in Different Phases of Clinical Development: Where Exactly Are We Lacking?

Sharma PK, Yadav M, Mehta N.

J Assoc Physicians India. 2024 Dec;72(12):49-54. doi: 10.59556/japi.72.0755.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias